Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Down 16.4% in December

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the recipient of a significant drop in short interest in December. As of December 15th, there was short interest totalling 65,900 shares, a drop of 16.4% from the November 30th total of 78,800 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF stock opened at C$3.89 on Monday. Vimian Group AB has a twelve month low of C$2.68 and a twelve month high of C$4.12. The company’s 50-day moving average price is C$3.63 and its 200-day moving average price is C$3.44.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.